Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

BMC Infectious Diseases

Table 3 Subgroup analysis (proportion of patients meeting exclusion criteria by gender and ethnicity)

Characteristic	SOF/VEL ASTRAL-1 No. excluded (%)	Difference (sig level)	GLE/PIB Expedition-2 No. excluded (%)	Difference (sig level)
Gender
Female (N = 72)	65 (90)		67 (93)
Male (N = 147)	130 (88)		131 (89)
		1.9% (p 0.673)		3.9% (p 0.359)
Ethnicity
Black (N = 117)	108 (92)		110 (94)
Non-black (N = 102)	87 (85)		88 (86)
		7% (p 0.099)		7.7% (p 0.054)

ISSN: 1471-2334